Contact: Brian McEvilly at: [email protected] SAN DIEGO, CA– Between 1.5 and 2 million people in the United States have lupus, an autoimmune disease, and according to the Lupus Foundation of America more than 70% of these patients suffer its most severe form: systemic lupus erythematosus, or SLE. Because its symptoms— which include joint and muscle pain, unexplained fevers and fatigue— …

Industry’s Most Advanced Test for Autoimmune CTD Achieves 50,000 Orders Albuquerque, N.M., April 28, 2015 – Exagen Diagnostics, Inc., a commercial-stage diagnostics company committed to addressing the significant unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases, announced today that its Avise SLE+ Connective Tissue 2.0 diagnostic has achieved the milestone of 50,000 orders …

Frank Witney, Ph.D. and John M. Radak, MBA Appointed Board Members Albuquerque, New Mexico and San Diego, California — (GLOBE NEWSWIRE) — September 22, 2014 —Exagen Diagnostics, a commercial-stage diagnostics company committed to addressing the significant unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases, today announced that Frank Witney, Ph.D. and John M. …

Contact: Blythe Lawton 760.560.1506 – [email protected] Albuquerque, N.M., June 9 , 2014 – Exagen Diagnostics Inc., a leading medical diagnostic company focused in rheumatology, today announced the addition of the Avise SLE Prognostic panel to its testing services. Designed to supplement the Avise SLE+ Connective Tissue diagnostic, Avise SLE Prognostic is acomprehensive prognostic panel that helps physicians assess potential risk …